Bruce A Cleveland's Net Worth

$379 Million

Estimate Recalculated Feb 16, 2024 04:30PM EST

Who is Bruce A Cleveland?

Bruce A Cleveland has an estimated net worth of $379 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., EnteroMedics Inc, Invuity, Inc., Trius Therapeutics Inc, GLAUKOS Corp, Eiger BioPharmaceuticals, Inc., Carbylan Therapeutics, Inc., C3.ai, Inc., Marketo, Inc., Transcept Pharmaceuticals Inc, and SIEBEL SYSTEMS INC.

SEC CIK

Bruce A Cleveland's CIK is 0001333063

Past Insider Trading and Trends

2014 was Bruce A Cleveland's most active year for acquiring shares with 32 total transactions. Bruce A Cleveland's most active month to acquire stocks was the month of January. 2014 was Bruce A Cleveland's most active year for disposing of shares, totalling 27 transactions. Bruce A Cleveland's most active month to dispose stocks was the month of April. 2010 saw Bruce A Cleveland paying a total of $9,397,557.48 for 3,548,643 shares, this is the most they've acquired in one year. In 2013 Bruce A Cleveland cashed out on 12,430,626 shares for a total of $70,818,664.12, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TESARO, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-19.53%
-600.00K
2.47M
Aug 5
Form 4
3.07M
$13.50
3.07M
Jul 3
Form 3
0
0
No matching records found

EnteroMedics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+724.94%
1.36M
1.55M
Nov 20
Form 4
187.5K
$8.00
$1,500,000.00
187.5K
Nov 15
Form 3
0
0
No matching records found

Invuity, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.08M
1.08M
Jun 18
Form 3
0
0
No matching records found

Trius Therapeutics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.55M
$4.77
3.55M
Aug 6
Form 3
0
0
No matching records found

GLAUKOS Corp (GKOS) Snapshot price: $94.39

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.6M
2.6M
Jun 30
Form 3
0
0
No matching records found